BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27232487)

  • 1. [High-throughput functional screening using CRISPR/Cas9 system].
    Wang GC; Ming M; Ye YZ; Xi JZ
    Yi Chuan; 2016 May; 38(5):391-401. PubMed ID: 27232487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput genetic screens using CRISPR-Cas9 system.
    Kweon J; Kim Y
    Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying synthetic lethal targets using CRISPR/Cas9 system.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional genetic screening using CRISPR-Cas9 system].
    Li H; Huang C
    Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):461-472. PubMed ID: 29701021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic screens and functional genomics using CRISPR/Cas9 technology.
    Hartenian E; Doench JG
    FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
    Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
    Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.
    Shen H; McHale CM; Smith MT; Zhang L
    Mutat Res Rev Mutat Res; 2015; 764():31-42. PubMed ID: 26041264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
    Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
    PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing.
    Bell CC; Magor GW; Gillinder KR; Perkins AC
    BMC Genomics; 2014 Nov; 15(1):1002. PubMed ID: 25409780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.
    Anderson EM; Haupt A; Schiel JA; Chou E; Machado HB; Strezoska Ž; Lenger S; McClelland S; Birmingham A; Vermeulen A; Smith Av
    J Biotechnol; 2015 Oct; 211():56-65. PubMed ID: 26189696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice.
    Weber J; Öllinger R; Friedrich M; Ehmer U; Barenboim M; Steiger K; Heid I; Mueller S; Maresch R; Engleitner T; Gross N; Geumann U; Fu B; Segler A; Yuan D; Lange S; Strong A; de la Rosa J; Esposito I; Liu P; Cadiñanos J; Vassiliou GS; Schmid RM; Schneider G; Unger K; Yang F; Braren R; Heikenwälder M; Varela I; Saur D; Bradley A; Rad R
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13982-7. PubMed ID: 26508638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
    Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
    J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.
    Zheng Q; Cai X; Tan MH; Schaffert S; Arnold CP; Gong X; Chen CZ; Huang S
    Biotechniques; 2014; 57(3):115-24. PubMed ID: 25209046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
    Li W; Ou G
    Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.
    Wang X; Wang Y; Wu X; Wang J; Wang Y; Qiu Z; Chang T; Huang H; Lin RJ; Yee JK
    Nat Biotechnol; 2015 Feb; 33(2):175-8. PubMed ID: 25599175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.